Podcast: Answers to Your Questions about QbD - - BioPharm International

ADVERTISEMENT

Podcast: Answers to Your Questions about QbD


Hundreds of listeners tuned into our recent web seminar on Quality by Design, and we didn’t have time to answer all their questions. Fortunately, our speakers gathered to answer the common questions in this podcast. Listen to hear their views on questions such as:

• What are the differences in how QbD is applied to a biotech drug substance and drug product?

• Does QbD only make sense for big companies?

• How can companies make pre-approval and post approval process changes under QbD?

Click here for the full web seminar on Quality by Design.

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines

Click here